drugset / Trial / NCT02620579

Biopsychosocial Influence on Shoulder Pain

NCT02620579

RandomizedParallel-groupTriple-blindTreatment

Summary

Chronic shoulder pain is a common, costly, and disabling problem for society. The identification of factors predictive of the development of chronic shoulder pain is necessary to develop innovative and effective treatments to reduce the societal impact of shoulder disorders. In previous work the investigators identified a genetic and psychological subgroup that robustly predicted heightened shoulder pain responses in a pre-clinical cohort and poor 12 month shoulder pain recovery rates in a clinical surgical cohort. In this follow-up study the investigator proposes to test how interventions tailored to the high risk subgroup affect pain responses in a pre-clinical cohort. The optimal theorized match for the identified high-risk subgroup is a combination of personalized pharmaceutical and education interventions. This combined personalized intervention versus a placebo pharmaceutical and general education intervention group is the primary comparison of interest. Also, an evaluation of the individual effect of personalized pharmaceutical and educational interventions will be part of the study. Such comparisons will provide important information on what the active portion of the combined personalized intervention may be.

Timeline

Start
2016-01
Primary completion
2021-11-05
Completion
2021-11-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Propranolol Small molecule 60 mg Oral

Indications

No indication recorded.